These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27100660)

  • 1. Drug-eluting balloons in the treatment of de-novo coronary lesions: a meta-analysis of randomized-controlled trials.
    Li Y; Wang C; Zuo G; Wang K; Cao Z; Du X
    Coron Artery Dis; 2016 Sep; 27(6):467-77. PubMed ID: 27100660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials.
    Cui K; Lyu S; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang D; Dai J
    PLoS One; 2017; 12(4):e0176365. PubMed ID: 28445555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Drug-Eluting Balloons for Patients With In-Stent Restenosis: A Meta-Analysis of 8 Randomized Controlled Trials.
    Gao S; Shen J; Mukku VK; Wang MJ; Akhtar M; Liu W
    Angiology; 2016 Aug; 67(7):612-21. PubMed ID: 26483569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis.
    Pleva L; Kukla P; Zapletalova J; Hlinomaz O
    BMC Cardiovasc Disord; 2017 Jun; 17(1):168. PubMed ID: 28651572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.
    Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK
    Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.
    Lee JM; Park J; Kang J; Jeon KH; Jung JH; Lee SE; Han JK; Kim HL; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2015 Mar; 8(3):382-394. PubMed ID: 25703886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
    Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials.
    Liu L; Liu B; Ren J; Hui G; Qi C; Wang J
    BMC Cardiovasc Disord; 2018 Mar; 18(1):46. PubMed ID: 29499651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting balloons for de novo coronary artery disease: a meta-analysis of angiographic and clinical data.
    Zhang T; Sun S; Shen L; He B
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1021-30. PubMed ID: 23703742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.
    Zhang D; Sun Y; Liu X; Liu F; Cheng Y; Ma X; Zhao Y; Zhou Y
    Angiology; 2019 May; 70(5):414-422. PubMed ID: 30384776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug eluting balloons for de novo coronary lesions - a systematic review and meta-analysis.
    Fröhlich GM; Lansky AJ; Ko DT; Archangelidi O; De Palma R; Timmis A; Meier P
    BMC Med; 2013 May; 11():123. PubMed ID: 23657123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R;
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
    Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials.
    Elgendy IY; Mahmoud AN; Elgendy AY; Mojadidi MK; Elbadawi A; Eshtehardi P; Pérez-Vizcayno MJ; Wayangankar SA; Jneid H; David Anderson R; Alfonso F
    Cardiovasc Revasc Med; 2019 Jul; 20(7):612-618. PubMed ID: 30126824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting balloons with provisional bail-out or adjunctive stenting in
    Patel S; Svermova T; Burke-Gaffney A; Bogle RG
    Cardiovasc Diagn Ther; 2018 Apr; 8(2):121-136. PubMed ID: 29850403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.